Pure Global
NCT06343129

Effects of a Whole-food, Plant-based Nutrition Program on BP and Potassium in Subjects With CKD

Effects of an Education Program Emphasizing a Whole-food, Plant-based Nutrition Program on Blood Pressure and Blood Potassium Levels in Subjects With Chronic Kidney Disease
University of Rochester·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
Dietary education program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Rochester
Location
Rochester,Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Oct 26, 2020
End date
Dec 12, 2022
Enrollment
43 participants
Primary outcome

Mean change in systolic blood pressure,Mean change in diastolic blood pressure,Mean change in potassium levels,Proportion of participants developing hyperkalemia

Summary

The purpose of this study is to determine if an educational program emphasizing a whole food
 plant based diet favorably impacts blood pressure while not significantly increasing blood
 potassium levels, by comparing a group of patients receiving the educational program with a
 control group of patients receiving no specific education.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06343129
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06343129 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Rochester and is currently Completed. The study focuses on Chronic Kidney Diseases. Target enrollment is 43 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.